Summary: In Phase 2 clinical trials, retatrutide was typically initiated at 2 mg once weekly via subcutaneous injection, with gradual dose escalation over several months under close medical supervision
This triple-agonist mechanism of action distinguishes it from currently available treatments such as Wegovy (which targets one receptor) and Mounjaro (which targets two)
This article compares oral and injectable GLP-1 treatments in terms of effectiveness, side effects, convenience, and cost, and examines new therapies in the pipeline expected to shape access in 2025 and beyond
Think of it as a helper that works after you eat
Include healthy fats: Opt for monounsaturated and omega-3 fatty acids from whole food sources like avocados, olive oil, and flaxseeds
Maar dat beeld klopt niet